Immunome, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2023 | — | -781.4% | -761.9% |
| FY2024 | — | -3,382.4% | -3,240.4% |
| FY2025 | — | -3,228.8% | -3,060.0% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2023 | — | -781.4% | -761.9% |
| FY2024 | — | -3,382.4% | -3,240.4% |
| FY2025 | — | -3,228.8% | -3,060.0% |